Alignment Healthcare LLC
NASDAQ: ALHC · HEALTHCARE · HEALTHCARE PLANS
Updated 2026-06-05
Alignment Healthcare LLC (ALHC) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for ALHC.
Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.
ALHC historical valuation range
Where current P/E sits in ALHC's own 5Y range.
ALHC intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
ALHC valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 197.50x
P/S Ratio — History
Current: 0.96x
Is ALHC overvalued in 2026?
Alignment Healthcare LLC (ALHC) currently trades at $17.16 per share with a market capitalization of $4,082,993,000.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 48/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 197.5x.
Our discounted cash flow model estimates ALHC's intrinsic value at $21.64 per share, against the current market price of $17.16. This implies a margin of safety of +5.78%. The stock is priced close to its estimated fair value, offering limited upside without further operational improvement.
The Piotroski F-Score of 4/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.
Bottom line: ALHC appears richly valued on our framework, with a Smart Value Score of 48/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.
Frequently asked questions
Is ALHC overvalued?
ALHC scores 48/100 on our Smart Value Score (Grade C), a weak overall profile. The DCF also shows a positive margin of safety, so price and fundamentals line up reasonably well.
What is ALHC's fair value?
Our DCF model estimates ALHC's intrinsic value at $21.64 per share, versus the current price of $17.16, a margin of safety of +5.78%. Fair value is the present value of the cash flows we project the business to produce, so a price below it means the market is pricing the stock below that conservative estimate.
What P/E ratio does ALHC trade at?
ALHC trades at a P/E of 197.5x on trailing twelve-month earnings. P/E is what you pay per dollar of profit.
Is ALHC a buy based on valuation?
Our Smart Value rating for ALHC is Sell, from a Smart Value Score of 48/100 that blends growth, quality, and valuation. The profile skews cautious, and a better price or clearer operating improvement would strengthen the case. This is research to inform your decision, not personalized financial advice.
How does ALHC's valuation compare to its history?
There is not enough historical valuation data yet for a confident percentile read on ALHC.
What is ALHC's Smart Value Score?
ALHC's Smart Value Score is 48/100. It is a proprietary WallStSmart metric blending growth quality, financial health, and valuation into a single 0-100 read, and scores above 75 are rare, signaling strong multi-factor alignment.